FI922142A0 - Enzymatisk resolution av endo- bicyklo/2.2.1/heptan-2-ol och daerav haerledda farmaceutiska aemnen. - Google Patents
Enzymatisk resolution av endo- bicyklo/2.2.1/heptan-2-ol och daerav haerledda farmaceutiska aemnen.Info
- Publication number
- FI922142A0 FI922142A0 FI922142A FI922142A FI922142A0 FI 922142 A0 FI922142 A0 FI 922142A0 FI 922142 A FI922142 A FI 922142A FI 922142 A FI922142 A FI 922142A FI 922142 A0 FI922142 A0 FI 922142A0
- Authority
- FI
- Finland
- Prior art keywords
- endo
- resolution
- haerledda
- enzymatisk
- aemnen
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C35/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring
- C07C35/22—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring polycyclic, at least one hydroxy group bound to a condensed ring system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/06—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D239/08—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms directly attached in position 2
- C07D239/10—Oxygen or sulfur atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C235/32—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton containing six-membered aromatic rings
- C07C235/34—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton containing six-membered aromatic rings having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
- C07C255/01—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
- C07C255/32—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring
- C07C255/37—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring the carbon skeleton being further substituted by etherified hydroxy groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
- C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
- C07C45/68—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
- C07C45/70—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form
- C07C45/71—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form being hydroxy groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C47/00—Compounds having —CHO groups
- C07C47/52—Compounds having —CHO groups bound to carbon atoms of six—membered aromatic rings
- C07C47/575—Compounds having —CHO groups bound to carbon atoms of six—membered aromatic rings containing ether groups, groups, groups, or groups
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P41/00—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture
- C12P41/003—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by ester formation, lactone formation or the inverse reactions
- C12P41/004—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by ester formation, lactone formation or the inverse reactions by esterification of alcohol- or thiol groups in the enantiomers or the inverse reaction
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/02—Preparation of oxygen-containing organic compounds containing a hydroxy group
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Pulmonology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Analytical Chemistry (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/US1989/005228 WO1991007501A1 (en) | 1989-11-13 | 1989-11-13 | Enzymatic resolution of endo-bicyclo[2.2.1]heptan-2-ol and derived pharmaceutical agents |
US8905228 | 1989-11-13 |
Publications (3)
Publication Number | Publication Date |
---|---|
FI922142A FI922142A (fi) | 1992-05-12 |
FI922142A0 true FI922142A0 (fi) | 1992-05-12 |
FI105106B FI105106B (fi) | 2000-06-15 |
Family
ID=22215375
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI922142A FI105106B (fi) | 1989-11-13 | 1992-05-12 | Menetelmä optisesti aktiivisen (2S)-endo-bisyklo[2.2.1]heptan-2-olin tai (2R)-endo-bisyklo[2.2.1]heptan-2-olin valmistamiseksi ja menetelmässä käytettävät välituotteet |
Country Status (27)
Country | Link |
---|---|
EP (2) | EP0801135A1 (fi) |
JP (1) | JPH06104661B2 (fi) |
KR (1) | KR930004654B1 (fi) |
CN (1) | CN1040423C (fi) |
AT (1) | ATE158577T1 (fi) |
AU (3) | AU633157B2 (fi) |
CA (1) | CA2029705C (fi) |
CZ (2) | CZ280006B6 (fi) |
DE (1) | DE69031487T2 (fi) |
DK (1) | DK0428302T3 (fi) |
EG (1) | EG19860A (fi) |
ES (1) | ES2107420T3 (fi) |
FI (1) | FI105106B (fi) |
GR (1) | GR3025196T3 (fi) |
HU (2) | HU215441B (fi) |
IE (2) | IE904059A1 (fi) |
IL (5) | IL110568A (fi) |
MY (1) | MY104517A (fi) |
NO (1) | NO304838B1 (fi) |
NZ (1) | NZ236037A (fi) |
PH (1) | PH30255A (fi) |
PL (4) | PL165132B1 (fi) |
PT (1) | PT95855B (fi) |
RU (1) | RU2104306C1 (fi) |
WO (1) | WO1991007501A1 (fi) |
YU (1) | YU48413B (fi) |
ZA (1) | ZA909044B (fi) |
Families Citing this family (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HU215441B (hu) * | 1989-11-13 | 1999-04-28 | Pfizer Inc. | Eljárás az endo-biciklo [2.2.1]-heptan-2-ol előállítására és az ebből kapott hatóanyagok enzimatikus úton történő elválasztására |
US5124455A (en) * | 1990-08-08 | 1992-06-23 | American Home Products Corporation | Oxime-carbamates and oxime-carbonates as bronchodilators and anti-inflammatory agents |
IE71647B1 (en) | 1991-01-28 | 1997-02-26 | Rhone Poulenc Rorer Ltd | Benzamide derivatives |
WO1993011256A1 (fr) * | 1991-12-06 | 1993-06-10 | Shionogi Seiyaku Kabushiki Kaisha | Procede de production d'un norborneol presentant une activite optique |
PL309257A1 (en) * | 1992-12-02 | 1995-10-02 | Pfizer | Pirocatechin doethers as selective inhibitors of ped iv |
US5814651A (en) * | 1992-12-02 | 1998-09-29 | Pfizer Inc. | Catechol diethers as selective PDEIV inhibitors |
JP3431204B2 (ja) * | 1993-04-22 | 2003-07-28 | 塩野義製薬株式会社 | ノルボルナン型エステル・ヒドロラーゼ |
CN1041436C (zh) * | 1993-05-07 | 1998-12-30 | 佛山市制药一厂 | 一种稳定冯了性风湿跌打药酒的方法 |
US5482944A (en) * | 1993-07-13 | 1996-01-09 | Pfizer Inc. | Pyrimidones and imidazolinones for treatment of shock |
JPH1142095A (ja) * | 1997-07-25 | 1999-02-16 | Chisso Corp | 新規なオキソジシクロペンタジエンの製造方法 |
KR100479019B1 (ko) * | 1998-05-22 | 2005-08-29 | 씨제이 주식회사 | 캐테콜히드라존유도체,이의제조방법및그를함유한약제학적조성물 |
HU229439B1 (hu) | 1999-08-21 | 2013-12-30 | Takeda Gmbh | Roflumilast és salmeterol szinergetikus kombinációja |
EP1405844A4 (en) | 2001-06-29 | 2006-09-20 | Nikken Chemicals Co Ltd | CYCLOALKENONDERIVAT |
ES2194588B1 (es) * | 2001-07-13 | 2004-10-16 | Astur Pharma S.A. | Precursores opticamente puros de paroxetina. |
US7772188B2 (en) | 2003-01-28 | 2010-08-10 | Ironwood Pharmaceuticals, Inc. | Methods and compositions for the treatment of gastrointestinal disorders |
AU2004226353A1 (en) | 2003-04-01 | 2004-10-14 | Laboratoires Serono Sa | Inhibitors of phosphodiesterases in infertility |
US8969514B2 (en) | 2007-06-04 | 2015-03-03 | Synergy Pharmaceuticals, Inc. | Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases |
US7879802B2 (en) | 2007-06-04 | 2011-02-01 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders |
US20100120694A1 (en) | 2008-06-04 | 2010-05-13 | Synergy Pharmaceuticals, Inc. | Agonists of Guanylate Cyclase Useful for the Treatment of Gastrointestinal Disorders, Inflammation, Cancer and Other Disorders |
ES2624828T3 (es) | 2008-07-16 | 2017-07-17 | Synergy Pharmaceuticals Inc. | Agonistas de la guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros |
US9616097B2 (en) | 2010-09-15 | 2017-04-11 | Synergy Pharmaceuticals, Inc. | Formulations of guanylate cyclase C agonists and methods of use |
MX357121B (es) | 2011-03-01 | 2018-06-27 | Synergy Pharmaceuticals Inc Star | Proceso de preparacion de agonistas c de guanilato ciclasa. |
US9545446B2 (en) | 2013-02-25 | 2017-01-17 | Synergy Pharmaceuticals, Inc. | Agonists of guanylate cyclase and their uses |
AU2014235209B2 (en) | 2013-03-15 | 2018-06-14 | Bausch Health Ireland Limited | Guanylate cyclase receptor agonists combined with other drugs |
CA2905438A1 (en) | 2013-03-15 | 2014-09-25 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase and their uses |
EP3004138B1 (en) | 2013-06-05 | 2024-03-13 | Bausch Health Ireland Limited | Ultra-pure agonists of guanylate cyclase c, method of making and using same |
JP6694385B2 (ja) | 2013-08-09 | 2020-05-13 | アーデリクス,インコーポレーテッド | リン酸塩輸送阻害のための化合物及び方法 |
US20200368223A1 (en) | 2019-05-21 | 2020-11-26 | Ardelyx, Inc. | Methods for inhibiting phosphate transport |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4261995A (en) * | 1979-08-31 | 1981-04-14 | Syntex (U.S.A.) Inc. | 4-Phenyl-and 5-phenyl-1,4,5,6-tetrahydropyrimidine derivatives |
US4732853A (en) * | 1984-11-21 | 1988-03-22 | President And Fellows Of Harvard College | Method of making chiral epoxy alcohols |
WO1987006576A1 (en) * | 1986-04-29 | 1987-11-05 | Pfizer Inc. | Calcium independent camp phosphodiesterase inhibitor antidepressant |
HU215441B (hu) * | 1989-11-13 | 1999-04-28 | Pfizer Inc. | Eljárás az endo-biciklo [2.2.1]-heptan-2-ol előállítására és az ebből kapott hatóanyagok enzimatikus úton történő elválasztására |
-
1989
- 1989-11-13 HU HUP9201587A patent/HU215441B/hu not_active IP Right Cessation
- 1989-11-13 RU SU5052372A patent/RU2104306C1/ru not_active IP Right Cessation
- 1989-11-13 CZ CS921240A patent/CZ280006B6/cs not_active IP Right Cessation
- 1989-11-13 WO PCT/US1989/005228 patent/WO1991007501A1/en active IP Right Grant
- 1989-11-13 HU HU9802988A patent/HU220962B1/hu not_active IP Right Cessation
-
1990
- 1990-11-02 AT AT90312019T patent/ATE158577T1/de not_active IP Right Cessation
- 1990-11-02 DK DK90312019.4T patent/DK0428302T3/da active
- 1990-11-02 EP EP97103886A patent/EP0801135A1/en not_active Ceased
- 1990-11-02 EP EP90312019A patent/EP0428302B1/en not_active Expired - Lifetime
- 1990-11-02 DE DE69031487T patent/DE69031487T2/de not_active Expired - Fee Related
- 1990-11-02 ES ES90312019T patent/ES2107420T3/es not_active Expired - Lifetime
- 1990-11-06 IL IL11056890A patent/IL110568A/en active IP Right Grant
- 1990-11-06 IL IL9626190A patent/IL96261A/en active IP Right Grant
- 1990-11-06 IL IL110564A patent/IL110564A/en active IP Right Grant
- 1990-11-09 CA CA002029705A patent/CA2029705C/en not_active Expired - Fee Related
- 1990-11-11 EG EG67090A patent/EG19860A/xx active
- 1990-11-12 PL PL90301764A patent/PL165132B1/pl unknown
- 1990-11-12 KR KR1019900018244A patent/KR930004654B1/ko not_active IP Right Cessation
- 1990-11-12 PT PT95855A patent/PT95855B/pt not_active IP Right Cessation
- 1990-11-12 CN CN90109076A patent/CN1040423C/zh not_active Expired - Fee Related
- 1990-11-12 PL PL90292070A patent/PL164457B1/pl unknown
- 1990-11-12 AU AU66535/90A patent/AU633157B2/en not_active Ceased
- 1990-11-12 IE IE405990A patent/IE904059A1/en not_active IP Right Cessation
- 1990-11-12 PL PL90292069A patent/PL164202B1/pl unknown
- 1990-11-12 NZ NZ236037A patent/NZ236037A/en unknown
- 1990-11-12 PL PL90287727A patent/PL164176B1/pl unknown
- 1990-11-12 YU YU214290A patent/YU48413B/sh unknown
- 1990-11-12 IE IE19980174A patent/IE980174A1/en not_active IP Right Cessation
- 1990-11-12 MY MYPI90001992A patent/MY104517A/en unknown
- 1990-11-12 ZA ZA909044A patent/ZA909044B/xx unknown
- 1990-11-13 JP JP2306942A patent/JPH06104661B2/ja not_active Expired - Fee Related
- 1990-11-13 CZ CS905609A patent/CZ280011B6/cs not_active IP Right Cessation
-
1992
- 1992-05-12 NO NO921876A patent/NO304838B1/no unknown
- 1992-05-12 FI FI922142A patent/FI105106B/fi not_active IP Right Cessation
-
1993
- 1993-01-22 AU AU31979/93A patent/AU645449B2/en not_active Ceased
- 1993-02-09 AU AU32920/93A patent/AU3292093A/en not_active Withdrawn
- 1993-10-12 PH PH47065A patent/PH30255A/en unknown
-
1994
- 1994-08-04 IL IL11056494A patent/IL110564A0/xx unknown
- 1994-08-04 IL IL11056894A patent/IL110568A0/xx unknown
-
1997
- 1997-10-29 GR GR970402831T patent/GR3025196T3/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI922142A0 (fi) | Enzymatisk resolution av endo- bicyklo/2.2.1/heptan-2-ol och daerav haerledda farmaceutiska aemnen. | |
FI892313A (fi) | Menetelmä tasolasin tai tasolasituotteiden optisen laadun määräämistä varten | |
FI895228A0 (fi) | Integrerad optisk anordning foer maetning av brytningsindex hos vaetskan. | |
AU6881791A (en) | Mammalian pancreatic cholesterol esterase | |
FI990018A0 (fi) | Elektronisuihkun pyyhkäisynopeuden modulointilaite | |
AU625144B2 (en) | Production method for optical fiber base material | |
AU4008589A (en) | Optical beam scanning apparatus | |
AU580668B2 (en) | A new process for the optical resolution of racemic mixtures of ``-naphthylpropionic acids | |
DK164060C (da) | Fremgangsmaade til fremstilling af 7-amino-3-alkoxymethyl-3-cephem-4-carboxylsyrer samt fremgangsmaade til fremstilling af et 7-acyleret cephalosporin-antibiotikum ved acylering af en saadan 7-amino-3-alkoxymethyl-3-cephem-4-carboxylsyre | |
EP0728708A3 (en) | Method of manufacturing a stable polarized optical fiber | |
FI904389A0 (fi) | Anordning och foerfarande foer reducering av distortion i ett analogt optiskt transmisonssystem. | |
BE887172A (fr) | Commande de synchronisation d'un lecteur de disques optiques | |
CS829588A2 (en) | Telecentric optical system of objective for wobbled laser beam focusing | |
GB9011302D0 (en) | Novel techniques for the fabrication of optical microstructures | |
GB9001972D0 (en) | Novel techniques for the fabrication of optical microstructures | |
DK33189D0 (da) | Apparat til fremvisning af hastigheden for et koeretoej | |
CS396287A1 (en) | Method of display on laser's focusing screen | |
FI894190A (fi) | Anordning foer betraktning av kartor och orientering. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MA | Patent expired |